{
  "id": "626aeab6e764a5320400003e",
  "type": "factoid",
  "question": "When was Volanesorsen approved in the EU?",
  "ideal_answer": "In May 2019, volanesorsen was approved in the EU for the treatment of adult patients with familial chylomicronemia syndrome.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31301033"
  ],
  "snippets": [
    {
      "text": "In May 2019, volanesorsen was approved in the EU for the treatment of adult patients with FCS based on positive results from the multinational, phase\u00a0III APPROACH and COMPASS studies. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31301033",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "May 2019"
}